WebCardiomyocyte-like cells (CMLCs) differentiated from PomD-iPSCs recapitulated the hallmark Pompe disease pathophysiological phenotypes, including high levels of glycogen and multiple ultrastructural aberrances. Drug rescue assessment showed that exposure of PomD-iPSC-derived CMLCs to recombinant human GAA reversed the major pathologic … WebJun 16, 2024 · Induced pluripotent stem cells (iPSCs) have the ability to differentiate into cardiomyocytes (CMs). They are not only widely used in cardiac pharmacology screening, human heart disease modeling, and cell transplantation-based treatments, but also the most promising source of CMs for experimental and clinical applications.
Strategies for Improving the Maturity of Human Induced …
WebMar 29, 2024 · Cardiac lipotoxicity is an important contributor to cardiovascular complications during obesity. Given the fundamental role of the endoplasmic reticulum (ER)-resident Selenoprotein T (SELENOT) for cardiomyocyte differentiation and protection and for the regulation of glucose metabolism, we took advantage of a small peptide (PSELT), … WebSep 17, 2024 · Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes … grantstown mr big
Action potential morphology of human induced pluripotent stem …
WebInduced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) allow us to recapitulate the disease phenotypes in vitro . Phenotypic screening on these cells would allow us to test different drug treatments to see if the drugs rescued the contractile and metabolic function in the in vitro DCM model [ 9 ]. WebMar 27, 2024 · Therefore, maintaining a fused mitochondrial network represents a beneficial approach to preventing cardiomyocyte hypertrophic growth, as Mul1-KD did in the … WebMar 29, 2024 · Analyzing in vitro contractile performance of human amniotic fluid-derived stem cells-induced pluripotent stem cell-derived cardiomyocyte (hAFSC-iPSC-CM) and human embryonic stem cell-derived cardiomyocyte (hESC-CM). An automated non-profit software, MUSCLEMOTION, was used to quantitate the in vitro contractile performance. grants townsville